Tirzepatide

Tirzepatide is a medication that belongs to a class of drugs called GLP-1 receptor agonists. They help control appetite and food cravings while also optimizing your metabolism and blood sugar levels.

Tirzepatide works by mimicking the action of the hormones glucagon-like-peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both play a role in weight loss. Tirzepatide increases insulin secretion, decreases glucagon secretion, slows down gastric emptying, and promotes a feeling of fullness, all of which help with weight loss.

Yes. Research shows that people who take tirzepatide lose about 21% of their body weight over 36 weeks. 

Midi’s compounded tirzepatide is delivered by self-injection once weekly. The medication comes with easy-to-follow instructions that do not require any prior medical training or experience.

Patients report a mild pinprick sensation and small area of skin irritation. To avoid irritating the same site, we recommend rotating your site of injection each week. Commonly used injection sites include: the outer area of the upper arm, the abdomen (avoiding a 2-inch circle around the navel), and the front of the thigh.

Midi’s tirzepatide starts at $254 per month, plus $35 for refrigerated shipping.

Common side effects can include decreased appetite, abdominal pain or upset stomach, indigestion, nausea, constipation, and diarrhea. Midi clinicians help you manage these side effects, which often improve with adjusted dosing over time.

Tirzepatide is generally considered safe for most people when used as prescribed. However, like any medication, it may not be suitable for everyone. Your Midi clinician will review your medical history and discuss any concerns you may have before prescribing tirzepatide.

Many patients cannot access brand name tirzepatide due to insurance coverage plan exclusions as well as manufacturing shortages and supply issues. Compounded tirzepatide injectables are safe, effective, reliable, and affordable.

Midi’s compounded tirzepatide is prepared by strictly regulated pharmacies that are licensed and approved for safety. It’s important to adhere closely to dosage instructions to ensure safe and effective weight loss while minimizing potential side effects. 

Research shows that some people can maintain their weight loss after coming off the medication, while others need ongoing, but often lower or intermittent, dosing. Once you reach your goal weight, your Midi clinician will partner with you to figure out the best maintenance plan. This may or may not include coming off the medication.

We recommend using safeneedledisposal.org to find out your state’s specific rules on sharps disposal. Most states allow you to place your used syringes and needles in a hard plastic container (ex. coffee tin or laundry detergent bottle), duct tape the top shut, and use your normal trash (not recycling).

Tirzepatide is a subcutaneous or “SC” injection, which means that the injection is given in the fatty tissue, just under the skin. That is why we administer tirzepatide into the squishy fat of the upper arm, front thigh, or abdomen. Subcutaneous injections differ from intramuscular (IM) injections, which involve injecting medication deep into a muscle.